Compugen Financials - Benzinga

Compugen Ltd

CGENNASDAQ

Trade with Public

Trade with Public

$2.49

0.031.22%

At close: Sep 18, 5:00 PM EST

$2.48

-0.01-0.4%

After Hours: 6:27 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Compugen Financials

Compugen (CGEN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Compugen Q2 EPS $(0.07), Inline, Sales $2.602M Beat $1.606M Estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 12.5 percent increase over losses of $(0.08) per share from the same period last year. The

Benzinga Newsdesk

Earnings Scheduled For May 18, 2026

Benzinga Insights

PRO
Compugen Q1 EPS $(0.08) Misses $(0.07) Estimate, Sales $2.176M Beat $2.095M Estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 14.29 percent. This is unchanged from the same period last year. The company reported

Benzinga Newsdesk

Earnings Breakdown: Compugen Q4

Benzinga Insights

PRO
Compugen Q4 EPS $0.60 Beats $0.05 Estimate, Sales $67.332M Beat $1.357M Estimate

Compugen (NASDAQ:CGEN) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.05 by 1100 percent. This is a 957.14 percent increase over losses of $(0.07) per share from the same

Benzinga Newsdesk

Earnings Scheduled For March 2, 2026

Benzinga Insights